Kingmed Diagnostics(SH:603882) Xin Lang Cai Jing·2025-11-19 06:10Core Viewpoint - The stock of Kingmed Diagnostics has experienced fluctuations, with a recent decline of 2.00% and a year-to-date increase of 12.08%, indicating volatility in its market performance [1]. Financial Performance - For the period from January to September 2025, Kingmed Diagnostics reported a revenue of 4.538 billion yuan, a year-on-year decrease of 19.23%, and a net profit attributable to shareholders of -796.095 million yuan, representing a significant decline of 184.84% [2]. - The company has distributed a total of 2.545 billion yuan in dividends since its A-share listing, with 1.647 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Kingmed Diagnostics was 41,700, a decrease of 1.60% from the previous period, with an average of 11,042 circulating shares per shareholder, an increase of 1.62% [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 35.5057 million shares, which is a reduction of 2.8676 million shares from the previous period [3]. Market Activity - The stock has seen a trading volume of 73.3667 million yuan with a turnover rate of 0.53%, and the total market capitalization stands at 13.838 billion yuan [1]. - Kingmed Diagnostics has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on February 7 [1].